3' IgH enhancer elements shift synergistic interactions during B cell development

Journal of Immunology

Volumn 160, Issue 10, 1998, Pages 4896-4903

  Ong, Jane ^a   Stevens, Sean ^b   Roeder, Robert G ^b   Eckhardt, Laurel A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; ENHANCER ELEMENTS (GENETICS); IMMUNOGLOBULIN HEAVY CHAINS; MICE; MICE, INBRED BALB C; RATS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0032525053     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Banerji, J., L. Olson, and W. Schaffner. 1983. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy-chain genes. Cell 33:729.
2. Gillies, S. D., S. L. Morrison, V. T. Oi, and S. Tonegawa. 1983. A tissue-specific transcriptional enhancer element is located in the major intron of a rearranged immunoglobulin heavy-chain gene. Cell 33:717.
3. Neuberger, M. S. 1983. Expression and regulation of immunoglobulin heavy chain genes transfected into lymphoid cells. EMBO J. 2:1373.
4. Serwe, M., and F. Sablitzky. 1993. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. EMBO J. 12:2321.
5. H locus. EMBO J. 12:4635.
6. Aguilera, R. J., T. J. Hope, and H. Sakano. 1985. Characterization of immunoglobulin enhancer deletions in murine plasmacytomas. EMBO J. 4:3689.
7. Eckhardt, L. A., and B. K. Birshtein. 1985, Independent immunoglobulin class-switch events occurring in a single myeloma cell line. Mol. Cell. Biol. 5:856.
8. Klein, S., F. Sablitsky, and A. Radbruch. 1984. Deletion of the IgH enhancer does not reduce immunoglobulin heavy chain production of a hybridoma IgD class switch variant. EMBO J. 3:2473.
9. Wabl, M. R., and P. D. Burrows. 1984. Expression of immunoglobulin heavy chain at a high level in the absence of a proposed immunoglobulin enhancer element in cis. Proc. Natl. Acad. Sci. USA 81:2452.
10. Zaller, D. M., and L. A. Eckhardt. 1985. Deletion of a B-cell-specific enhancer affects transfected, but not endogenous, immunoglobulin heavy-chain gene expression. Proc. Natl. Acad. Sci. USA 82:5088.
11. Dariavach, P., G. T. Williams, K. Campbell, S. Pettersson, and M. S. Neuberger. 1991. The mouse IgH 3′-enhancer. Eur. J. Immunol. 21:1499.
12. Lieberson, R., S. L. Giannini, B. K. Birshtein, and L. A. Eckhardt. 1991. An enhancer at the 3′end of the mouse immunoglobulin heavy chain locus. Nucleic Acids Res. 19:933.
13. Lieberson, R., J. Ong, X. Shi, and L. A. Eckhardt. 1995. Transcription of an immunoglobulin gene ceases upon deletion of a distant enhancer. EMBO J. 14:6229.
14. Cogne, M., R. Lansford, A. Bottaro, J. Zheng, J. German, K. F. Young, H. L. Cheng, and F. W. Alt. 1994. A class switch control region at the 3′ end of the immunoglobulin heavy chain locus. Cell 77:737.
15. Fiering, S., C. G. Kim, E. M. Epner, and M. Groudine. 1993. An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: analysis of the β-globin locus control region. Proc. Natl. Acad. Sci. USA 90:8469.
16. Kim, C. G., E. M. Epner, W. C. Forrester, and M. Groudine. 1992. Inactivation of the human beta-globin gene by targeted insertion into the β-globin locus control region. Genes Dev. 6:928.
17. Matthias, P., and D. Baltimore. 1993. The immunoglobulin heavy chain locus contains another B-cell-specific 3′ enhancer close to the α constant region. Mol. Cell. Biol. 13:1547.
18. Saleque, S., M. Singh, R. D. Little, S. L. Giannini, J. S. Michaelson, and B. K. Birshtein. 1997. Dyad symmetry within the mouse 3′IgH regulatory region includes two virtually identical enhancers (Cα3′E and hs3). J. Immunol. 158:4780.
19. Madisen, L., and M. Groudine. 1994. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma und Burkitt's lymphoma cells. Genes Dev. 8:2212.
20. Michaelson, J. S., S. L. Giannini, and B. K. Birshtein. 1995. Identification of 3′α-HS4, a novel Ig heavy chain enhancer element regulated at multiple stages of B cell differentiation. Nucleic Acids Res. 23:975.
21. Chaveau, C., and M. Cogne. 1996. Palindromic structure of the IgH 3′ locus control region. Nat. Genet. 14:15.
22. Fulton, R., and B. Van Ness. 1994. Selective synergy of immunoglobulin enhancer elements in B cell development: a characteristic of κ light chain enhancers, but not heavy chain enhancers. Nucleic Acids Res. 22:4216.
23. Singh, M., and B. K. Birshtein. 1996. Concerted repression of an immunoglobulin heavy-chain enhancer, 3′αE (hs1, 2). Proc. Natl. Acad. Sci. USA 93:4392.
24. Singh, M., and B. K. Birshtein. 1993. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′α enhancer at early stages of B cell differentiation. Mol. Cell. Biol. 13:3611.
25. Arulampalam, V., P. A. Grant, A. Samuelsson, U. Lendahl, and S. Pettersson. 1994. Lipopolysaccharide-dependent transactivation of the temporally regulated immunoglobulin heavy chain 3′ enhancer. Eur. J. Immunol. 24:1671.
26. Grant, P. A., C. B. Thompson, and S. Pettersson. 1995. IgM receptor-mediated transactivation of the IgH 3′ enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function. EMBO J. 14:4501.
27. Grant, P. A., T. Andersson, M. F. Neurath, V. Arulampalam, A. Bauch, R. Muller, M. Reth, and S. Pettersson. 1996. A T cell controlled molecular pathway regulating the IgH locus: CD40-mediated activation of the IgH 3′ enhancer. EMBO J. 15:6691.
28. Bain, G., E. C. Maandag, D. J. Izon, D. Amsen, A. M. Kruisbeek, B. C. Weintraub, I. Krop, M. S. Schlissel, A. J. Feeney, M. Roon, M. Valk, H. J. Riele, A. Berns, and C. Murre. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885.
29. Zhuang, Y., P. Soriano, and H. Weintraub. 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875.
30. Urbanek, P., Z. Wang, I. Fetka, F. E. Wagner, and M. Busslinger. 1992. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79:901.
31. Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573.
32. Siden, E. J., D. Baltimore, D. Clark, and N. E. Rosenberg. 1979. Immunoglobulin synthesis by lymphoid cells transformed in vitro by Abelson murine leukemia virus. Cell 16:389.
33. - sublines. J. Immunol. 122:549.
34. Glimcher, L. H., T. Hamano, R. Asofsky, E. Heber-Katz, S. Hedrick, R. H. Schwartz, and W. E. Paul. 1982. I region-restricted antigen presentation by B cell-B lymphoma hybridomas. Nature 298:283.
35. Rabbits, T. H., P. H. Hamlyn, and R. Baer. 1983. Altered nucleotide sequence of a translocated c-myc gene in Burkitt lymphoma. Nature 306:760.
36. Jain, V. K., J. G. Judde, E. E. Max, and I. T. Magrath. 1993. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation. J. Immunol. 150:5418.
37. Topp, W. C. 1981. Normal rat cell lines deficient in nuclear thymidine kinase. Virology 113:408.
38. Zaller, D. M., H. Yu, and L. A. Eckhardt. 1988. Genes activated in the presence of an immunoglobulin enhancer or promoter are negatively regulated by a T-lymphoma cell line. Mol. Cell. Biol. 8:1932.
39. Gauss, G. H., and M. R. Lieber. 1992. DEAE-dextran enhances electroporation of mammalian cells. Nucleic Acids Res. 20:6739.
40. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456.
41. Fulton, R., and B. Van Ness. 1993. κ immunoglobulin promoters and enhancers display developmentally controlled interactions. Nucleic Acids Res. 21:4941.
42. Garcia, J. V., L. Bich-Thuy, J. Stafford, and C. Queen. 1986. Synergism between immunoglobulin enhancers and promoters. Nature 322:383.
43. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1988. Identification of a novel lymphoid specific octamer binding protein (OTF-2B) by proteolytic clipping bandshift assay (PCBA). EMBO J. 7:4221.
44. Muller-Immergluck, M. M., W. Schaffner, and P. Matthias. 1990. Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells. EMBO J. 9:1625.
45. Schubart, D., P. Sauter, S. Massa, E. Friedl, H. Schwarzenbach, and P. Matthias. 1996. Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1. Nucleic Acids Res. 24:1913.
46. Seipel, K., O. Georgiev, and W. Schaffner. 1992. Different activation domains stimulate transcription from remote ("enhancer") and proximal ("promoter") positions. EMBO J. 11:4961.
47. Mills, F., N. Harindranath, M. Mitchell, and E. Max. 1997. Enhancer complexes located downstream of both human immunoglobulin C α genes. J. Exp. Med. 186:845.
48. Chen, C., and B. K. Birshtein. 1997. Virtually identical enhancers containing a segment of homology to murine 3′IgH-E(hsI, 2) lie downstream of human Ig Cα1 and Cα2 genes. J. Immunol. 159:1310.
49. Giannini, S. L., M. Singh, C. F. Calvo, G. Ding, and B. K. Birshtein. 1993. DNA regions flanking the mouse Ig 3′alpha enhancer are differentially methylated and DNase I hypersensitive during B cell differentiation. J. Immunol. 150:1772.
50. Riley, S. C., E. J. Brock, and W. M. Kuehl. 1981. Induction of light chain expression in a pre-B cell line by fusion to myeloma cells. Nature 289:804.
51. Mocikat, R., C. Kardinal, and H. Klobeck. 1995. Differential interactions between the immunoglobulin heavy chain μ intron and 3′ enhancer. Eur. J. Immunol. 25:3195.
52. Arulampalam, V., L. Eckhardt, and S. Pettersson. 1997. The enhancer shift: a model to explain the developmental control of IgH gene expression in B-lineage cells. Immunol. Today 18:549.
53. Natkunam, Y., X. Zhang, Z. Liu, and S. Chen-Kiang. 1994. Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6. J. Immunol. 153:3476.
54. Chen-Kiang, S., W. Hsu, Y. Natkunam, and X. Zhang. 1993. Nuclear signaling by interleukin-6. Curr. Opin. Immunol. 5:124.
55. Singh, H., R. Sen, D. Baltimore, and P. A. Sharp. 1986. A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 319:154.
56. Corcoran, L. M., M. Karvelas, G. J. Nossal, Z. S. Ye, T. Jacks, and D. Baltimore. 1993. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7:570.
57. Radomska, H. S., C. P. Shen, T. Kadesch, and L. A. Eckhardt. 1994. Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma × T cell hybrids. Immunity 1:623.
58. Corcoran, L. M., and M. Karvelas. 1994. Oct-2 is required early in T cell-independent B cell activation for G1 progression and for proliferation. Immunity 1:6553.